Literature DB >> 14687886

Regulation of dendrite formation of Purkinje cells by serotonin through serotonin1A and serotonin2A receptors in culture.

Mayumi Kondoh1, Takashi Shiga, Nobuo Okado.   

Abstract

Serotonergic fibers and receptors appear in the rat cerebellum during early postnatal development. In the present study, we investigated the actions of serotonin (5-HT) and its receptors in the dendrite formation of Purkinje cells in organotypic cultures of anterior and posterior lobes of the cerebellum at postnatal day 7. In anterior lobes after 4 days in vitro (4DIV), the dendritic areas and branchings of Purkinje cells were increased by the treatment of 2 microM 5-HT, but decreased by 20 microM 5-HT. In posterior lobes after 4DIV, the dendritic areas of Purkinje cells were increased by 5-HT (2, 20 and 200 microM). In contrast, 5-HT treatment decreased dendritic areas of Purkinje cells in both anterior and posterior lobes after 7DIV. Next, we determined the actions of specific 5-HT receptors in mediating the effects of 5-HT by treatment with selective 5-HT receptor agonists. In anterior lobes after 4DIV, dendritic areas of Purkinje cells were increased by a 5-HT1A receptor agonist (8-OH-DPAT), whereas decreased by a 5-HT2A receptor agonist (DOI). The present study suggested that the dendrite formation of Purkinje cells is promoted by 5-HT through 5-HT1A receptors, but inhibited by 5-HT through 5-HT2A receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14687886     DOI: 10.1016/j.neures.2003.10.001

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  8 in total

1.  Mother/offspring co-administration of the traditional herbal remedy yokukansan during the nursing period influences grooming and cerebellar serotonin levels in a rat model of neurodevelopmental disorders.

Authors:  Katsumasa Muneoka; Makiko Kuwagata; Tetsuo Ogawa; Seiji Shioda
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

2.  Clinical characterization of the HOXA1 syndrome BSAS variant.

Authors:  T M Bosley; M A Salih; I A Alorainy; D T Oystreck; M Nester; K K Abu-Amero; M A Tischfield; E C Engle
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

3.  Developmental regulation of GABAergic interneuron branching and synaptic development in the prefrontal cortex by soluble neural cell adhesion molecule.

Authors:  Leann Hinkle Brennaman; Patricia F Maness
Journal:  Mol Cell Neurosci       Date:  2008-01-17       Impact factor: 4.314

Review 4.  Medullary serotonin defects and respiratory dysfunction in sudden infant death syndrome.

Authors:  David S Paterson; Gerard Hilaire; Debra E Weese-Mayer
Journal:  Respir Physiol Neurobiol       Date:  2009-05-27       Impact factor: 1.931

5.  Serotonergic pharmacotherapy promotes cortical reorganization after spinal cord injury.

Authors:  Patrick D Ganzer; Karen A Moxon; Eric B Knudsen; Jed S Shumsky
Journal:  Exp Neurol       Date:  2012-12-19       Impact factor: 5.330

6.  Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT3A and 5-HT6 receptor subtypes.

Authors:  Tania Vitalis; Mark S Ansorge; Alexandre G Dayer
Journal:  Front Cell Neurosci       Date:  2013-06-19       Impact factor: 5.505

7.  Serotonin regulates mitochondrial biogenesis and function in rodent cortical neurons via the 5-HT2A receptor and SIRT1-PGC-1α axis.

Authors:  Sashaina E Fanibunda; Sukrita Deb; Babukrishna Maniyadath; Praachi Tiwari; Utkarsha Ghai; Samir Gupta; Dwight Figueiredo; Noelia Weisstaub; Jay A Gingrich; Ashok D B Vaidya; Ullas Kolthur-Seetharam; Vidita A Vaidya
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-09       Impact factor: 11.205

Review 8.  Maturation, Refinement, and Serotonergic Modulation of Cerebellar Cortical Circuits in Normal Development and in Murine Models of Autism.

Authors:  Eriola Hoxha; Pellegrino Lippiello; Bibiana Scelfo; Filippo Tempia; Mirella Ghirardi; Maria Concetta Miniaci
Journal:  Neural Plast       Date:  2017-08-15       Impact factor: 3.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.